In situ characterization of the human host response to Leishmania panamensis

American Journal of Dermatopathology

Volumn 19, Issue 6, 1997, Pages 585-590

  Palma, Gloria I ^a,b,c   Saravia, Nancy G ^b  

^a UNIVERSIDAD DEL VALLE   (Colombia)

^b Ctro Intl Entrenamiento InvestM   (Colombia)

^c CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

Author keywords

Cutaneous leishmaniasis; Immune response; Immunohistopathology; Leishmania panamensis; Viannia subgenus

Indexed keywords

ADULT; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; LEISHMANIA; LEISHMANIASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; T LYMPHOCYTE;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, PROTOZOAN; BIOLOGICAL MARKERS; BIOPSY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; EPIDERMIS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GRANULOCYTES; GRANULOMA; HUMANS; IMMUNITY, CELLULAR; IMMUNOHISTOCHEMISTRY; LEISHMANIA; LEISHMANIASIS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NECROSIS; REGRESSION ANALYSIS; SKIN;

EID: 0030785325     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199712000-00006     Document Type: Article

References (25)

1. Howard JG, Hale C, Liew FY. Immunological regulation of experimental cutaneous leishmaniasis. IV. Prophylactic effect of sublethal irradiation as a result of abrogation of suppressor T cell generation in mice genetically susceptible to Leishmania tropica. J Exp Med 1981;153:557-68.
2. Sacks DL, Scott PA, Asofsky R, Sher A. Cutaneous leishmaniasis in anti-IgM treated mice: enhanced resistance due to functional depletion of a B cell dependent T cell involved in the suppressor pathway. J Immunol 1984;132:2072-7.
3. Sadick MD, Heinzel FP, Holaday BJ, Pu RT, Dawkins R, Locksley RM. Curc of murine leishmaniasis with anti-interleukin 4 monoclonal antibody: evidence for a T cell dependent interferon γ independent mechanism. J Exp Med 1990;171:1115-27.
4. Scott P. IFN γ modulates the early development of Th1 and Th2 respesnses in a murine model of cutneous leishmaniasis. J Immunol 1991;147:3149-55.
5. Pirmez C. Immunopathology of American cutaneous leishmaniasis. Mem Inst Oswaldo Cruz 1992;87(suppl V):105-9.
6. Azulay RD. Histopatolofia da leishmaniose tegumentar. Derm ILA 1960;2:7-15.
7. Ridley DS. A histological classification of cutaneous leishmaniasis and its geographical expression, Trans R Soc Trop Med Hyg 1980; 74:515-21.
8. Magalhães AV, Moraes MA, Raick AN, et al. Histopatologia da leishmaniose tegumentar por Leishmania braziliensis braziliensis. 1. Padrões histopatologicos e estudo evolutivo das lesões. Rev Inst Med Trop São Paulo 1986;28:253-62.
9. Lima HC, Vasconcelos AW, David JR, Lerner EA. American cutaneous leishmaniasis: In situ charaeterization of the cellular immune response with time. Am J Trop Mad Hyg 1994;50:743-47.
10. World Health Organisation. Report of a workshop on the chemotherapy of mucocutaneous leishmaniasis. Brasilia, 10-14 July 1979.
11. Weigle KA, de Davalos M, Heredia P, Molineros R, Saravia NG, D'Alessandro A. Diagnosis of cutaneous and mueocutaneous leishmaniasis in Colombia: a comparison of seven methods. Am J Trop Med Hyg 1987;36:489-96.
12. Senekjie H.A. Studies on the culture of leishmania tropica. Trans R Soc Trop Med Hyg 1939;33:267-9.
13. Saravia NG, Holguin AF, McMahon-Pratt D, D'Alessamdro A. Mucocutaneous leishmaniasis in Colombia: Leishmania brazilien- sis subspecies diversity. Am J Trop Med Hyg 1985;34:714-20.
14. McMahon-Pratt D, David JR. Monoclonal antibodies that distinguish New World .species of Leishmania. Nature 1981;291:581-3.
15. Sokal JE. Ballpoint pen technique for measuring skin test reactions. N Engl Med 1975;293:501-2.
16. Saravia NG, Valderrama L, Labrada M, et al. The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis. J Infect Dis 1989; 159:725-35.
17. Salinas G, Valderrama L, Palma G, Montes G, Saravia NG. Deteccion de amastigoats en leishmaniasis cutanea y mucocutanea por el metodo de inmunoperoxidasa. usaddo anticuerpo policlonal: sensibilidad y especificidad comparadas con metodos convencionales de diagnostico. Mem Inst Oswaldo Cruz 1989;84:53-60.
18. Emerson JD, Stoto MA. Transforming data. In: Understanding robust and exploratory data analysis. Hoaglin DC, Mosteller F, Tukey JW, eds. New York: John Wiley and Sons. 1983:97-128.
19. Emerson JD. Mathematical aspects of transformation. In: Understanding robust and exploratory data analysis. Hoaglin DC, Mosteller F, Tukey JW, eds. New York: John Wiley and Sons. 1983: 247-82.
20. Da Cruz AM, Conceição-Silva F, Bertho AL, Coutinho SG. Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis. Infec Immun 1994;62:2614-8.
21. Wood GS, Warner NL, Warnke RA. Anti-Leu 3a/T4 antibodies react with cells of monicyte/macrophage and langerhans lineage. J Immunol 1983;131:212-6.
22. Bos JD, Kapsenberg ML. The skin immune system. Immunology Today 1987;7:235-40.
23. Scott P, Natovitz P, Sher A. B lymphocytes are required for the generation of T cells that mediate healing of cutaneous leishmaniasis. J Immunol 1986;137:1017-21.
24. Gutierrez Y, Salinas G, Palma G, Valderrama L, Santrich C, Saravia NG. Correlation between histopathology, immune response, clinical presentation and evolution in Leishmania braziliensis infection. Am J Trop Mad Hyg 1991;45:281-9.
25. Cuba CA, Marsden PD, Barreto AC, Rocha R, Sampaio RR, Patzlaff L. Parasitologic and immunologic diagnosis of American (mucocutaneous) leishmaniasis. Bull Pan Am Health Org 1981;15: 249-54.